Dirk Janssen

Summary

Affiliation: University of Kiel
Country: Germany

Publications

  1. ncbi Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry
    Dirk Janssen
    Department of Pediatric Pathology, University of Kiel, Kiel, Germany
    Am J Surg Pathol 29:21-8. 2005
  2. ncbi Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network
    Markus Tiemann
    Department of Haematopathology and Lymph Node Registry, University Hospitals of Schleswig-Holstein, Campus Kiel, Kiel, Germany
    Br J Haematol 131:29-38. 2005
  3. ncbi Repp86: a new prognostic marker in mantle cell lymphoma
    Carsten Schrader
    II Department of Internal Medicine and Hematology, University Hospital of Schleswig Holstein, Campus Kiel, Germany
    Eur J Haematol 75:498-504. 2005
  4. ncbi Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group
    Wolfram Klapper
    Department of Pathology, Hematopathology Section and Lymph Node Registry, Kiel, Germany
    J Clin Oncol 25:3330-6. 2007
  5. ncbi Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients
    Carsten Schrader
    II Department of Internal Medicine and Hematology, University Hospital of Schleswig Holstein, Kiel, Chemnitzstrasse 33, 24116 Kiel, Germany
    Virchows Arch 448:151-9. 2006
  6. ncbi AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping
    Christian Hoffmann
    Infectious Diseases Outpatient Clinic, II Department of Medicine, Universitatsklinikum Schleswig Holstein, Campus Kiel, Chemnitzstrasse 33, 24116 Kiel, Germany
    Blood 106:1762-9. 2005
  7. ncbi Human beta-defensin-2 in oral cancer with opportunistic Candida infection
    Jens Eduard Meyer
    Department of Otorhinolaryngology, Head and Neck Surgery, University of Schleswig Holstein, Campus Kiel, 24105 Kiel, Germany
    Anticancer Res 24:1025-30. 2004
  8. ncbi Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma
    Birgit Burkhardt
    Department of Pediatric Hematology and Oncology, Children's University Hospital, Giessen, Germany
    J Clin Oncol 24:491-9. 2006
  9. ncbi Clonality in juvenile xanthogranuloma
    Dirk Janssen
    Am J Surg Pathol 31:812-3. 2007
  10. ncbi Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker
    Alena Skalova
    Department of Pathology, Medical Faculty Hospital, Charles University, Plzen, Czech Republic
    Am J Surg Pathol 30:939-44. 2006

Collaborators

Detail Information

Publications11

  1. ncbi Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry
    Dirk Janssen
    Department of Pediatric Pathology, University of Kiel, Kiel, Germany
    Am J Surg Pathol 29:21-8. 2005
    ..JXG is an uncommon, mostly cutaneous, and prognostically favorable histiocytic tumor of infancy. Simple tumor excision is the therapy for choice except in the very rare systemic JXG, in which multimodal chemotherapy is indicated...
  2. ncbi Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network
    Markus Tiemann
    Department of Haematopathology and Lymph Node Registry, University Hospitals of Schleswig-Holstein, Campus Kiel, Kiel, Germany
    Br J Haematol 131:29-38. 2005
    ..Based on this large clinicopathological study of prospective clinical trials, multivariate analysis confirmed the central prognostic role of cell proliferation and its superiority to all other histomorphological and clinical criteria...
  3. ncbi Repp86: a new prognostic marker in mantle cell lymphoma
    Carsten Schrader
    II Department of Internal Medicine and Hematology, University Hospital of Schleswig Holstein, Campus Kiel, Germany
    Eur J Haematol 75:498-504. 2005
    ..Patients and..
  4. ncbi Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group
    Wolfram Klapper
    Department of Pathology, Hematopathology Section and Lymph Node Registry, Kiel, Germany
    J Clin Oncol 25:3330-6. 2007
    ..Several histopathologic biomarkers for risk stratification have been suggested, but most markers have not been validated in patients treated in prospective trials...
  5. ncbi Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients
    Carsten Schrader
    II Department of Internal Medicine and Hematology, University Hospital of Schleswig Holstein, Kiel, Chemnitzstrasse 33, 24116 Kiel, Germany
    Virchows Arch 448:151-9. 2006
    ..0008). The distribution of FDC in MCL is a diagnostic tool for identifying patients with a better clinical prognosis...
  6. ncbi AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping
    Christian Hoffmann
    Infectious Diseases Outpatient Clinic, II Department of Medicine, Universitatsklinikum Schleswig Holstein, Campus Kiel, Chemnitzstrasse 33, 24116 Kiel, Germany
    Blood 106:1762-9. 2005
    ..04). In summary, lack of CD20 or CD10 expression and a post-germinal center signature are associated with a worse prognosis in ARL...
  7. ncbi Human beta-defensin-2 in oral cancer with opportunistic Candida infection
    Jens Eduard Meyer
    Department of Otorhinolaryngology, Head and Neck Surgery, University of Schleswig Holstein, Campus Kiel, 24105 Kiel, Germany
    Anticancer Res 24:1025-30. 2004
    ..Malignant transformation induces alteration of hBD-2 expression and leads to a reduced hBD-2 expression and subsequentially to Candida colonization on oral SCCs...
  8. ncbi Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma
    Birgit Burkhardt
    Department of Pediatric Hematology and Oncology, Children's University Hospital, Giessen, Germany
    J Clin Oncol 24:491-9. 2006
    ..CONCLUSION: For CNS-negative patients with stage III or IV LBL and sufficient response to induction therapy, treatment without PCRT may be noninferior to treatment including PCRT...
  9. ncbi Clonality in juvenile xanthogranuloma
    Dirk Janssen
    Am J Surg Pathol 31:812-3. 2007
  10. ncbi Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker
    Alena Skalova
    Department of Pathology, Medical Faculty Hospital, Charles University, Plzen, Czech Republic
    Am J Surg Pathol 30:939-44. 2006
    ..We therefore conclude that the findings in the present study are further supporting evidence that SPA is a neoplasm, and not just a reactive process...
  11. ncbi A 38-year history of natural-killer-cell lymphoma
    Carsten Schrader
    N Engl J Med 350:418-9. 2004